Pluri Inc.

PLUR ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2016 FY2015 FY2014 FY2013 FY2012
Revenue $2.8M $379.0K $379.0K $679.0K $716.0K
Cost of Revenue $100.0K $13.0K $11.0K $20.0K $21.0K
Gross Profit $2.7M $366.0K $368.0K $659.0K $695.0K
Gross Margin 96.5% 96.6% 97.1% 97.1% 97.1%
Operating Expenses
Research & Development $22.9M $23.4M $24.9M $19.9M $12.7M
SG&A Expense $6.5M $6.5M $8.7M $5.6M $6.6M
Operating Income $-23.3M $-25.3M $-27.9M $-22.2M $-15.0M
Operating Margin -819.1% -6,666.8% -7,348.3% -3,272.9% -2,099.3%
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-23.2M $-24.7M $-26.9M $-21.2M $-14.8M
Net Margin -816.5% -6,511.1% -7,106.1% -3,115.6% -2,066.2%
EPS (Basic) $-0.29 $-0.35 $-0.42 $-0.38 $-0.34
EPS (Diluted) $-0.29 $-0.35 $-0.42 $-0.38 $-0.34
Shares Outstanding (Basic) 80.7M 79.1M 69.3M 59.2M 47.5M
Shares Outstanding (Diluted) 80.7M 79.1M 69.3M 59.2M 47.5M
Dividends Per Share
← Newer Page 2 of 2 Older →